# CABERGOLINE

NDC: 27808-315
Generic name: CABERGOLINE
Labeler / Manufacturer: Cranbury Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260801

FDA application: ANDA220309

## Active ingredients

- CABERGOLINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27808-315"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27808-315
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8562f94f-a59a-4893-aefc-ea6547b01e92